In vitro fertilization outcome triggered with different dosage of GnRH and hCG in antagonist protocol

Comparing in vitro fertilization outcomes in antagonist protocol triggering within 3 groups of GnRH agonist, hCG, dual ( GnRH and hCG) in infertile women

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160130026260N2

Enrollment

108

Registered

2020-03-23

Start date

2020-03-11

Completion date

Unknown

Last updated

2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility patients going ivf. Female infertility

Interventions

Intervention 1: Intervention group: Administration of 0.2 mg Dipherellin on the triggering day of ovulation. Intervention 2: Intervention group: Administration of 0.2 mg Dipherellin and 1500 unit HCG

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 18-40 years women Follicular stimulating hormone lower than 12U/lit menstruation interval 25-34days Having both ovaries infertile women

Exclusion criteria

Exclusion criteria: Endocrine disease uterine anomaly

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy rate. Timepoint: 2 months after embryo transfer. Method of measurement: Ultrasonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShaghayegh Moradi Alamdarloo

Shiraz University of Medical Sciences

shaghayeghmoradi84@gmail.com+98 71 3233 2365

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026